Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
54 studies found for:    "Synovitis"
Show Display Options
Rank Status Study
21 Completed The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients
Condition: Rheumatoid Arthritis
Intervention: Drug: certolizumab pegol
22 Completed A Case Control Study to Define Clinical, Immunologic and Radiographic Features of the Aromatase Inhibitor Arthralgia Syndrome
Conditions: Arthralgia Syndrome;   Arthritis;   Synovitis
23 Unknown  Preliminary Study of Sonic Hedgehog Signaling Pathway in the Pathogenesis of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid;   Neovascularization, Pathologic;   Synovitis
24 Recruiting A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor
Conditions: Solid Tumors;   Tenosynovial Giant Cell Tumor;   Synovitis, Pigmented Villonodular
Intervention: Drug: PLX73086
25 Not yet recruiting Characteristics of Rheumatoid Arthritis Patients With Atlantoaxial Synovitis Detected by Plain X-ray and MRI
Condition: Neck Pain
Interventions: Radiation: Plain X-ray;   Radiation: Magnetic resonance imaging
26 Active, not recruiting Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint Replacements
Conditions: Edematous;   Synovitis;   Foreign Body Reaction;   Osteolysis
Interventions: Drug: Placebo;   Drug: Apatone®B
27 Completed Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee
Conditions: Synovitis;   Osteoarthritis;   Joint Diseases;   Muskuloskeletal Diseases
Interventions: Drug: Chondroitin sulphate (Condrosan);   Drug: Placebo
28 Completed Intra-Articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-Blind Randomized Study
Condition: Rheumatoid Arthritis
Interventions: Procedure: intra-articular injection of etanercept;   Procedure: intra-articular injection of steroid
29 Completed Efficacy of Bisphosphonates in Patients With Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome
Condition: SAPHO Syndrome
Intervention: Drug: pamidronate disodium
30 Completed
Has Results
A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography
Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept;   Drug: Methotrexate
31 Completed
Has Results
Intra-articular Glucocorticoid Treatment of the Elbow
Condition: Rheumatoid Arthritis
Intervention: Behavioral: immobilisation in a triangular sling
32 Completed Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Biological: Rituximab
33 Not yet recruiting Tenosynovial Giant Cell Tumors (TGCT) Observational Platform Project
Condition: Giant Cell Tumors
34 Completed
Has Results
A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis.
Condition: Rheumatoid Arthritis
Interventions: Drug: rituximab [MabThera/Rituxan];   Drug: Methotrexate
35 Active, not recruiting The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients
Condition: Rheumatoid Arthritis
Intervention: Drug: corticotrophin 80 units
36 Withdrawn A Study of The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDs
Condition: Rheumatoid Arthritis
Interventions: Drug: methotrexate;   Drug: tocilizumab [RoActemra/Actemra]
37 Completed
Has Results
A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs
Condition: Rheumatoid Arthritis
Interventions: Drug: DMARDs;   Drug: Tocilizumab
38 Completed
Has Results
A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDs
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra];   Drug: placebo;   Drug: non-biological DMARDs
39 Completed
Has Results
A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
Condition: Active Rheumatoid Arthritis
Interventions: Drug: Abatacept;   Drug: Placebo
40 Enrolling by invitation Prospective Analgesic Compound Efficacy (PACE) Study
Conditions: Arthritis;   Tendonitis;   Gout;   Radiculopathy;   Muscle Spasms;   Synovitis;   Migraine;   Headache
Interventions: Drug: baclofen 2%;   Drug: Bupivacaine hydrochloride 1%;   Drug: Cyclobenzaprine hydrochloride 2%;   Drug: Diclofenac Sodium 3%;   Drug: Flurbiprofen 10%;   Drug: Gabapentin 6%;   Drug: Ketamine 10%;   Drug: Lidocaine 2%;   Drug: Prilocaine 2.5%;   Drug: Meloxicam 0.09%;   Drug: Sumatriptan 5%;   Drug: Tizanidine 0.1%;   Drug: Topiramate 2.5%;   Drug: Capsaicin, USP 0.0375%;   Drug: Menthol, NF 5.00 %

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-54) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.